These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12782341)

  • 1. Cyclophosphamide induces dose- and time-dependent elevations in spleen norepinephrine levels of BALB/c mice.
    Karp JD; Szczytkowski JL
    Neurosci Lett; 2003 Jun; 344(2):117-21. PubMed ID: 12782341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenergic responses of peripheral organs to cyclophosphamide in mice.
    Karp JD; Szczytkowski JL; Gentile CF
    Life Sci; 2004 Sep; 75(17):2077-89. PubMed ID: 15312752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norepinephrine in mouse spleen shows minor strain differences and no diurnal variation.
    Kelley SP; Grota LJ; Felten SY; Madden KS; Felten DL
    Pharmacol Biochem Behav; 1996 Jan; 53(1):141-6. PubMed ID: 8848443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immuno-enhancement effects of Shenqi Fuzheng Injection on cyclophosphamide-induced immunosuppression in Balb/c mice.
    Wang J; Tong X; Li P; Cao H; Su W
    J Ethnopharmacol; 2012 Feb; 139(3):788-95. PubMed ID: 22212503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen.
    Sefc L; Psenák O; Sýkora V; Sulc K; Necas E
    J Hematother Stem Cell Res; 2003 Feb; 12(1):47-61. PubMed ID: 12662436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
    Hao J; Liu J; Xie S
    Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide.
    Mayumi H; Good RA
    J Exp Med; 1989 Jan; 169(1):213-38. PubMed ID: 2642528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation and suppression of graft-vs-host reactions by cyclophosphamide.
    Wander RH; Hilgard HR
    J Immunol; 1981 Mar; 126(3):901-4. PubMed ID: 7462635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of antigen-specific CD4+ Th2 cells and B cells in vivo increases norepinephrine release in the spleen and bone marrow.
    Kohm AP; Tang2 Y; Sanders VM; Jones3 SB
    J Immunol; 2000 Jul; 165(2):725-33. PubMed ID: 10878345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immuno-enhancement effects of Yifei Tongluo Granules on cyclophosphamide-induced immunosuppression in Balb/c mice.
    Wang Y; Qi Q; Li A; Yang M; Huang W; Xu H; Zhao Z; Li S
    J Ethnopharmacol; 2016 Dec; 194():72-82. PubMed ID: 27586820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin and cyclophosphamide lead to long-lasting impairment of spatial memory in female, but not male mice.
    Philpot RM; Ficken M; Wecker L
    Behav Brain Res; 2016 Jul; 307():165-75. PubMed ID: 27083301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells affect central and peripheral noradrenergic mechanisms and neurotrophin concentration in the spleen and hypothalamus.
    Jouda J; Wildmann J; Schäfer M; Roggero E; Besedovsky HO; del Rey A
    Ann N Y Acad Sci; 2012 Jul; 1261():18-25. PubMed ID: 22823389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathetic innervation, norepinephrine content, and norepinephrine turnover in orthotopic and spontaneous models of breast cancer.
    Szpunar MJ; Belcher EK; Dawes RP; Madden KS
    Brain Behav Immun; 2016 Mar; 53():223-233. PubMed ID: 26718447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose cyclophosphamide inhibits anterior chamber-associated immune deviation (ACAID) and the production of extracellular antigen-specific T cell proteins induced by trinitrophenylated (TNP) spleen cells.
    Wang Y; O'Rourke J; Cone RE
    Cell Immunol; 1995 Oct; 165(2):284-8. PubMed ID: 7553893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of cyclophosphamide on antibody formation in the mouse.
    Willers JM; Sluis E
    Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the spleen in cyclophosphamide-induced hematosuppression and extramedullary hematopoiesis in mice.
    Wang Y; Meng Q; Qiao H; Jiang H; Sun X
    Arch Med Res; 2009 May; 40(4):249-55. PubMed ID: 19608013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprotective and adjuvant effects of immunomodulator ginsan in cyclophosphamide-treated normal and tumor bearing mice.
    Shim JY; Han Y; Ahn JY; Yun YS; Song JY
    Int J Immunopathol Pharmacol; 2007; 20(3):487-97. PubMed ID: 17880762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemotherapy of transplantable Moloney leukemia with cyclophosphamide and allogeneic spleen lymphocytes and reversal of graft-versus-host disease with alloantiserum.
    Kende M; Keys LD; Gaston M; Goldin A
    Cancer Res; 1975 Feb; 35(2):346-51. PubMed ID: 234033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chemotherapeutic agents on natural cell-mediated cytotoxicity in mice.
    Mantovani A; Luini W; Peri G; Vecchi A; Spreafico F
    J Natl Cancer Inst; 1978 Nov; 61(5):1255-61. PubMed ID: 280711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of cyclophosphamide-suppressed primary immune response in mice by Tołpa Peat Preparation (TPP)--comparison with calf thymus extract.
    Obmińska-Domoradzka B
    Acta Pol Pharm; 1993; 50(6):501-6. PubMed ID: 8067263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.